000040762 000__ 02598cam\a2200805\i\4500 000040762 001__ 40762 000040762 003__ SzGeWIPO 000040762 005__ 20230317102313.0 000040762 008__ 200403s2018\\\\gw\a\\\\ob\\\\000\0\eng\d 000040762 020__ $$a9781108606851$$qe-book 000040762 035__ $$a(MiAaPQ)EBC4830532 000040762 035__ $$a(Au-PeEL)EBL4830532 000040762 035__ $$a(CaPaEBR)ebr11366866 000040762 035__ $$a(OCoLC)980702303 000040762 035__ $$a(wipo)EBC4830532 000040762 040__ $$aMiAaPQ$$beng$$erda$$cMiAaPQ 000040762 041__ $$aeng 000040762 08204 $$a344.5104233 000040762 1001_ $$aMercurio, Bryan. 000040762 24510 $$aDrugs, Patents and Policy : A Contextual Study of Hong Kong. 000040762 264_1 $$aCambridge, England, UK :$$bCambridge University Press,$$c2018. 000040762 300__ $$a1 online resource (242 pages) :$$billustrations 000040762 336__ $$atext$$2rdacontent 000040762 337__ $$acomputer$$2rdamedia 000040762 338__ $$aonline resource$$bcr$$2rdacarrier 000040762 5050_ $$a1. Introduction -- 2. The contextual framework of Hong Kong's pharmaceutical patent laws and policy -- 3. Standards of patentability -- 4. Extension of patent terms for pharmaceutical products -- 5. Exceptions to exclusive rights -- 6. Test data exclusivity -- 7. Patent linkage -- 8. Conclusion. 000040762 520__ $$aIn pharmaceutical patent law, the problem of lack of policy direction and inappropriate legal framework is widespread - particularly among jurisdictions with little to no pharmaceutical research or manufacturing. This book aims to inform public policy and influence debate through a comprehensive review of Hong Kong's pharmaceutical patent law. By demonstrating the need for a holistic review of pharmaceutical patent laws and evaluating Hong Kong's system in light of health policy, economic and social factors, Bryan Mercurio recommends changes to the legal framework and constructs a more efficient and effective system for Hong Kong. He thoroughly evaluates the international framework and best practice models to offer a global perspective to each issue before providing local context in the analysis. While the focus of the book is Hong Kong, the analysis on pharmaceutical patent law and policy extends to other jurisdictions facing issues on reforming their national system. Proposes a holistic approach to pharmaceutical patent law and policy based on the needs and priorities of Hong Kong All analysis and recommendations are well-grounded, feasible and in-line with developing norms The underlying issues, principles and arguments of the book are universally applicable and extended to other jurisdictions outside of Hong Kong 000040762 650_0 $$aPharmacy$$xLaw and legislation$$xChina$$xHong Kong 000040762 650_0 $$aDrugs$$xLaw and legislation$$xChina$$xHong Kong 000040762 650_0 $$aLaw$$xIntellectual Property 000040762 655_4 $$aElectronic books 000040762 85640 $$uhttps://ebookcentral.proquest.com/lib/wipo/detail.action?docID=5435973$$zView this Ebook 000040762 904__ $$aBook 000040762 942__ $$2ddc$$cEBOOK 000040762 980__ $$aBIB 000040762 980__ $$aOS